Showing results (271-280 of 716) with videos related to

Sort By:
Pageof 72
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemiaYesid Alvarado, Apostolia Tsimberidou, Hagop Kantarjian, et al.
Pharmacoeconomics|May 26, 2007
Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemiaTheodore Darkow, Henry J Henk, Simu K Thomas, et al.
Experimental Hematology|May 30, 2007
Imatinib effect on growth and signal transduction in polycythemia veraAmos Gaikwad, Srdan Verstovsek, Donghoon Yoon, et al.
Cancer|July 9, 2004
Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemiaCarlos E Bueso-Ramos, Jorge Cortes, Moshe Talpaz, et al.
Leukemia Research|June 12, 2017
Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosisLucia Masarova, Prithviraj Bose, Naval Daver, et al.
Leukemia & Lymphoma|January 19, 2010
Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remissionHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Haematologica|February 14, 2007
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemiaWanlong Ma, Richard Tseng, Mercedes Gorre, et al.
Haematologica|February 9, 2012
Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity TrialFrançois Guilhot, Timothy P Hughes, Jorge Cortes, et al.
Leukemia Research|January 18, 2003
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemiaEfrosyni Apostolidou, Elihu Estey, Jorge Cortes, et al.
Cancer|October 30, 2003
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phaseJorge Medina, Hagop Kantarjian, Moshe Talpaz, et al.
Pageof 72